Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Pain, Postoperative 3Pain 3Colorectal Neoplasms 2Supratentorial Neoplasms 1Prostatic Neoplasms 1Postoperative Complications 1Pancreatic Ductal Adenocarcinoma 1Pain, Intractable 1Oropharyngeal Neoplasms 1Neoplasms 1Meningioma 1Lung Neoplasms 1Liver Neoplasms 1Liver Diseases 1Colonic Neoplasms 1Cancer Pain 1Breast Neoplasms 1Benign Gynecologic Neoplasm 1Agnosia 1Acute Pain 1Abdominal Neoplasms 1

Interventions

Pharmaceutical Services 2Lidocaine 2Ethanol 2Acetaminophen 2Venlafaxine Hydrochloride 1Ropivacaine 1Radiofrequency Ablation 1Pregabalin 1Oxycodone 1Myofascial Release Therapy 1Morphine 1Methadone 1Memantine 1Ketamine 1Hospitals 1Gels 1Dronabinol 1Cholecalciferol 1Calcium Dobesilate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Cancer Pain × Ropivacaine × Clear all
NCT04085120 2019-09-11

Ropivacaine/Dexamethasone and 10% Lignocaine Injection in GPN Block for Intractable Cancer Pain

All India Institute of Medical Sciences

Phase NA Unknown
60 enrolled
Head & Neck

Cancer Pain, Oropharyngeal Neoplasms, Pain, Intractable

Data powered by HemOnc (CC BY 4.0) Colophon âš¡